We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.77%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHGG icon
426
Chegg
CHGG
$102M
$1.18M 0.05%
+17,465
New +$933K
CYRX icon
427
CryoPort
CYRX
$762M
$1.18M 0.05%
+38,849
New +$864K
SNX icon
428
TD Synnex
SNX
$20.2B
$1.17M 0.05%
19,514
+19,394
+16,162% +$906K
CI icon
429
Cigna
CI
$74.6B
$1.17M 0.05%
6,222
+6,161
+10,100% +$1.17M
HSIC icon
430
Henry Schein
HSIC
$9.82B
$1.17M 0.05%
19,955
+11,598
+139% +$648K
NEU icon
431
NewMarket
NEU
$8.18B
$1.16M 0.05%
2,900
+2,214
+323% +$913K
KIE icon
432
State Street SPDR S&P Insurance ETF
KIE
$639M
$1.16M 0.05%
42,323
-55,230
-57% -$1.46M
BLK icon
433
Blackrock
BLK
$176B
$1.16M 0.05%
2,127
+952
+81% +$481K
SPGP icon
434
Invesco S&P 500 GARP ETF
SPGP
$2.3B
$1.16M 0.05%
21,032
-573
-3% -$29.8K
FHN icon
435
First Horizon
FHN
$12.1B
$1.15M 0.05%
115,888
+115,661
+50,952% +$1.05M
RLI icon
436
RLI Corp
RLI
$5.89B
$1.15M 0.05%
28,056
+27,210
+3,216% +$1.07M
ORLY icon
437
O'Reilly Automotive
ORLY
$76.3B
$1.15M 0.05%
40,905
+17,910
+78% +$468K
CIEN icon
438
Ciena
CIEN
$58.4B
$1.15M 0.05%
21,218
+7,628
+56% +$379K
MDYG icon
439
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.95B
$1.14M 0.05%
21,220
-1,092
-5% -$54.4K
WING icon
440
Wingstop
WING
$3.18B
$1.14M 0.05%
+8,186
New +$954K
AGG icon
441
iShares Core US Aggregate Bond ETF
AGG
$138B
$1.14M 0.05%
9,622
+2,451
+34% +$287K
INDB icon
442
Independent Bank
INDB
$3.97B
$1.14M 0.05%
+16,937
New +$1.14M
WSM icon
443
Williams-Sonoma
WSM
$29.6B
$1.14M 0.05%
27,720
+26,114
+1,626% +$888K
ABMD
444
DELISTED
Abiomed Inc
ABMD
$1.14M 0.05%
4,696
+4,006
+581% +$804K
FLO icon
445
Flowers Foods
FLO
$1.57B
$1.13M 0.05%
50,661
+31,941
+171% +$720K
ADSK icon
446
Autodesk
ADSK
$52.6B
$1.13M 0.05%
4,730
+4,560
+2,682% +$896K
NUVA
447
DELISTED
NuVasive, Inc.
NUVA
$1.13M 0.05%
20,318
+20,276
+48,276% +$1.17M
PLMR icon
448
Palomar
PLMR
$3.45B
$1.13M 0.05%
+13,118
New +$870K
GARP
449
iShares MSCI USA Quality GARP ETF
GARP
$2.75B
$1.12M 0.05%
43,561
-3,747
-8% -$88.6K
MRCY icon
450
Mercury Systems
MRCY
$6.52B
$1.12M 0.05%
+14,275
New +$1.17M

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.